OMER FY 2023 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$165M

Net Income

-$118M

EPS (Diluted)

$-1.88

Cash Flow

Operating Cash Flow

$75M

Free Cash Flow

$74M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$378M

Total Liabilities

$403M

Stockholders' Equity

-$25M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$165M	-$163M	-0.7%
Net Income	-$118M	$47M	-348.5%